EVEROLIMUS

EVEROLIMUS was reported 49664 times

EVEROLIMUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 97 0.4059
1 ANGIOFIBROMA 26 0.3514
2 PANCREATIC NEUROENDOCRINE TUMOUR 177 0.2761
3 BRAIN STEM GLIOMA 32 0.2105
4 PIK3CA-ACTIVATED MUTATION 68 0.2048
5 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 42 0.1772
6 POLYOMAVIRUS VIRAEMIA 182 0.1714
7 BLOOD CHROMOGRANIN A INCREASED 75 0.1634
8 NEUROENDOCRINE TUMOUR 227 0.1602
9 INSULINOMA 26 0.1469
10 CARCINOID TUMOUR PULMONARY 33 0.1369
11 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 308 0.1313
12 METASTASES TO SKIN 135 0.1307
13 GAMMA-GLUTAMYLTRANSFERASE DECREASED 25 0.1302
14 CARCINOID CRISIS 29 0.1283
15 ANGIOMYOLIPOMA 26 0.1209
16 METASTASES TO THE MEDIASTINUM 45 0.1092
17 METASTASES TO THORAX 27 0.1067
18 METASTASES TO CHEST WALL 36 0.1037
19 HORMONE RECEPTOR POSITIVE BREAST CANCER 27 0.0993
20 METASTASES TO PLEURA 104 0.0991
21 MICROSPORIDIA INFECTION 34 0.0969
22 MYCOBACTERIUM HAEMOPHILUM INFECTION 26 0.0909
23 BK VIRUS INFECTION 305 0.0903
24 VIRAEMIA 125 0.0902
25 HUMAN POLYOMAVIRUS INFECTION 47 0.0885
26 NEPHRITIC SYNDROME 27 0.0871
27 CARBOHYDRATE ANTIGEN 15-3 INCREASED 66 0.0867
28 METASTASES TO PANCREAS 36 0.0813
29 METASTATIC RENAL CELL CARCINOMA 143 0.0781
30 METASTASES TO ABDOMINAL CAVITY 37 0.0752
31 METASTASES TO LIVER 1272 0.0723
32 LYMPHANGIOSIS CARCINOMATOSA 74 0.0710
33 CELL MARKER INCREASED 34 0.0710
34 BREAST CANCER METASTATIC 730 0.0679
35 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 80 0.0667
36 METASTASES TO BONE 1060 0.0645
37 CARCINOID TUMOUR 48 0.0645
38 METASTASES TO ADRENALS 59 0.0639
39 PARVOVIRUS B19 INFECTION 55 0.0615
40 METASTASES TO SPINE 205 0.0609
41 METASTASES TO LUNG 697 0.0603
42 LYMPHOCELE 40 0.0602
43 METASTASES TO KIDNEY 33 0.0599
44 GASTRIC ANTRAL VASCULAR ECTASIA 31 0.0586
45 TUMOUR MARKER INCREASED 267 0.0556
46 STOMATITIS 3196 0.0526
47 LIVER TRANSPLANT REJECTION 93 0.0517
48 LUNG TRANSPLANT REJECTION 34 0.0515
49 HEART TRANSPLANT REJECTION 53 0.0511
50 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 260 0.0510
51 HUMAN HERPESVIRUS 8 INFECTION 31 0.0509
52 METASTASES TO LYMPH NODES 335 0.0496
53 HEPATIC LESION 212 0.0490
54 TUMOUR PAIN 63 0.0478
55 METASTASES TO PERITONEUM 119 0.0471
56 HEPATITIS E 74 0.0468
57 MALIGNANT NEOPLASM PROGRESSION 4746 0.0463
58 ONCOLOGIC COMPLICATION 44 0.0455
59 RENAL CANCER METASTATIC 35 0.0455
60 PNEUMONITIS 1220 0.0448
61 CONCOMITANT DISEASE PROGRESSION 86 0.0440
62 RENAL TRANSPLANT FAILURE 43 0.0435
63 COMPLICATIONS OF TRANSPLANTED KIDNEY 98 0.0432
64 RENAL TUBULAR ATROPHY 38 0.0431
65 METASTASES TO PELVIS 27 0.0427
66 TRANSPLANT REJECTION 340 0.0424
67 DELAYED GRAFT FUNCTION 28 0.0394
68 PNEUMOCYSTIS JIROVECII INFECTION 46 0.0385
69 CHRONIC ALLOGRAFT NEPHROPATHY 30 0.0383
70 ANAL ULCER 31 0.0379
71 APHTHOUS ULCER 294 0.0379
72 CLEAR CELL RENAL CELL CARCINOMA 26 0.0374
73 RENAL CELL CARCINOMA 180 0.0368
74 DEVICE RELATED THROMBOSIS 35 0.0355
75 TUMOUR NECROSIS 37 0.0350
76 ABDOMINAL LYMPHADENOPATHY 30 0.0346
77 ORAL PAIN 761 0.0340
78 KIDNEY FIBROSIS 57 0.0328
79 MALIGNANT PLEURAL EFFUSION 55 0.0326
80 BONE LESION 116 0.0321
81 EPSTEIN-BARR VIRAEMIA 35 0.0316
82 HEPATIC NEOPLASM 103 0.0315
83 BILE DUCT STENOSIS 37 0.0309
84 METASTASIS 219 0.0306
85 KIDNEY TRANSPLANT REJECTION 147 0.0306
86 BREAST CANCER RECURRENT 95 0.0300
87 NEOPLASM PROGRESSION 1037 0.0298
88 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 98 0.0296
89 SECOND PRIMARY MALIGNANCY 245 0.0294
90 MOUTH ULCERATION 606 0.0287
91 LYMPHADENOPATHY MEDIASTINAL 55 0.0287
92 APHTHOUS STOMATITIS 66 0.0286
93 THROMBOTIC MICROANGIOPATHY 275 0.0282
94 MUCOSAL INFLAMMATION 735 0.0280
95 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 36 0.0273
96 HEPATIC MASS 52 0.0270
97 MOUTH INJURY 40 0.0264
98 BONE NEOPLASM 28 0.0260
99 LUNG INFILTRATION 225 0.0254
100 MEAN CELL HAEMOGLOBIN DECREASED 45 0.0246
101 EPSTEIN-BARR VIRUS INFECTION 150 0.0240
102 HYPERTRIGLYCERIDAEMIA 138 0.0235
103 TRANSPLANT DYSFUNCTION 42 0.0235
104 NONINFECTIVE GINGIVITIS 34 0.0235
105 REFLUX GASTRITIS 28 0.0233
106 CARCINOEMBRYONIC ANTIGEN INCREASED 45 0.0232
107 CYTOMEGALOVIRUS COLITIS 51 0.0222
108 LUNG CONSOLIDATION 62 0.0221
109 METASTASES TO CENTRAL NERVOUS SYSTEM 285 0.0221
110 LYMPHOEDEMA 151 0.0218
111 INVASIVE DUCTAL BREAST CARCINOMA 59 0.0217
112 CYTOMEGALOVIRUS TEST POSITIVE 38 0.0213
113 CONCOMITANT DISEASE AGGRAVATED 131 0.0212
114 CANCER PAIN 54 0.0211
115 PANCREATIC NEOPLASM 26 0.0210
116 CYTOMEGALOVIRUS INFECTION 337 0.0203
117 DRUG LEVEL DECREASED 204 0.0200
118 JC VIRUS INFECTION 32 0.0200
119 ORAL MUCOSAL EXFOLIATION 30 0.0198
120 RENAL NEOPLASM 42 0.0198
121 NEOPLASM 225 0.0196
122 PYELONEPHRITIS ACUTE 38 0.0194
123 METASTASES TO MENINGES 44 0.0193
124 CHOLANGITIS 118 0.0190
125 RECURRENT CANCER 77 0.0189
126 NASAL DISCHARGE DISCOLOURATION 26 0.0188
127 CREPITATIONS 56 0.0188
128 LIVER ABSCESS 60 0.0185
129 HAEMOLYTIC URAEMIC SYNDROME 42 0.0181
130 TONGUE ULCERATION 61 0.0180
131 ASCITES 526 0.0179
132 CACHEXIA 92 0.0179
133 BODY TEMPERATURE DECREASED 176 0.0179
134 PNEUMONIA PSEUDOMONAL 27 0.0176
135 EXPOSED BONE IN JAW 38 0.0175
136 PLEURAL EFFUSION 1054 0.0173
137 OSTEONECROSIS OF JAW 422 0.0170
138 ONYCHOCLASIS 117 0.0170
139 PNEUMONIA CYTOMEGALOVIRAL 33 0.0170
140 RENAL MASS 35 0.0170
141 INGROWING NAIL 40 0.0169
142 VARICELLA ZOSTER VIRUS INFECTION 35 0.0169
143 BILE DUCT OBSTRUCTION 32 0.0169
144 ESCHERICHIA SEPSIS 48 0.0165
145 DYSLIPIDAEMIA 84 0.0165
146 HYPERGLYCAEMIA 599 0.0164
147 BLOOD PRESSURE SYSTOLIC INCREASED 318 0.0163
148 NAIL DISORDER 140 0.0160
149 ORGANISING PNEUMONIA 78 0.0157
150 VENA CAVA THROMBOSIS 26 0.0156
151 INTERSTITIAL LUNG DISEASE 756 0.0156
152 ADENOVIRUS INFECTION 45 0.0155
153 SQUAMOUS CELL CARCINOMA OF SKIN 93 0.0154
154 PNEUMOCYSTIS JIROVECII PNEUMONIA 153 0.0152
155 PROTEINURIA 288 0.0151
156 ODYNOPHAGIA 90 0.0151
157 TONGUE BLISTERING 33 0.0148
158 SOFT TISSUE INFECTION 27 0.0147
159 BONE CANCER 64 0.0147
160 ACTINIC KERATOSIS 38 0.0146
161 HEPATIC PAIN 62 0.0145
162 EATING DISORDER 309 0.0145
163 BLOOD CREATININE DECREASED 45 0.0144
164 HYPOPHOSPHATAEMIA 104 0.0141
165 BLOOD LACTATE DEHYDROGENASE INCREASED 222 0.0140
166 SUBILEUS 29 0.0139
167 DRUG LEVEL INCREASED 230 0.0139
168 CELL DEATH 27 0.0136
169 ORTHOPNOEA 43 0.0135
170 BLOOD TRIGLYCERIDES INCREASED 238 0.0135
171 HYPERCHOLESTEROLAEMIA 130 0.0135
172 CYTOMEGALOVIRUS INFECTION REACTIVATION 59 0.0133
173 METASTATIC NEOPLASM 57 0.0132
174 VASODILATATION 33 0.0131
175 DISEASE PROGRESSION 1534 0.0130
176 CHRONIC GRAFT VERSUS HOST DISEASE 46 0.0127
177 SKIN TOXICITY 72 0.0127
178 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 296 0.0127
179 CYTOMEGALOVIRUS VIRAEMIA 56 0.0126
180 BLOOD PHOSPHORUS DECREASED 46 0.0126
181 PULMONARY MASS 185 0.0124
182 NEPHROPATHY TOXIC 139 0.0124
183 BLOOD CREATININE ABNORMAL 42 0.0121
184 BLOOD PRESSURE DIASTOLIC DECREASED 89 0.0120
185 LUNG NEOPLASM 51 0.0119
186 FEEDING DISORDER 238 0.0117
187 GAMMA-GLUTAMYLTRANSFERASE INCREASED 260 0.0117
188 PERICARDIAL EFFUSION 271 0.0117
189 RALES 67 0.0115
190 PROTEIN TOTAL DECREASED 43 0.0114
191 NEOPLASM MALIGNANT 759 0.0114
192 CHEILITIS 61 0.0113
193 PERFORMANCE STATUS DECREASED 52 0.0111
194 GINGIVAL SWELLING 49 0.0111
195 HYDRONEPHROSIS 83 0.0111
196 COMA SCALE ABNORMAL 32 0.0110
197 BLOOD CREATININE INCREASED 721 0.0110
198 PULMONARY TOXICITY 78 0.0110
199 RENAL TUBULAR NECROSIS 108 0.0110
200 GINGIVAL PAIN 87 0.0109
201 INJECTION SITE HYPERSENSITIVITY 34 0.0109
202 TUMOUR HAEMORRHAGE 31 0.0109
203 SPINAL PAIN 127 0.0108
204 CHAPPED LIPS 47 0.0108
205 LUNG DISORDER 525 0.0107
206 C-REACTIVE PROTEIN INCREASED 389 0.0107
207 URINARY TRACT INFECTION BACTERIAL 27 0.0107
208 NORMOCHROMIC NORMOCYTIC ANAEMIA 32 0.0106
209 PATHOLOGICAL FRACTURE 54 0.0106
210 HYPOPHAGIA 268 0.0105
211 ATELECTASIS 100 0.0103
212 ENTEROCOCCAL INFECTION 50 0.0103
213 EPISTAXIS 768 0.0103
214 HYPERURICAEMIA 42 0.0102
215 LYMPHOCYTE COUNT DECREASED 180 0.0102
216 URINE OUTPUT DECREASED 89 0.0102
217 BLOOD CHOLESTEROL INCREASED 472 0.0101
218 BLOOD PRESSURE DIASTOLIC INCREASED 46 0.0100
219 BLOOD UREA INCREASED 164 0.0098
220 JAUNDICE CHOLESTATIC 34 0.0096
221 HYPERLIPIDAEMIA 115 0.0096
222 BLOOD ALBUMIN DECREASED 76 0.0096
223 TERMINAL STATE 64 0.0096
224 ESCHERICHIA INFECTION 78 0.0095
225 BLOOD ALKALINE PHOSPHATASE INCREASED 235 0.0095
226 ORAL DISORDER 69 0.0094
227 PORTAL HYPERTENSION 29 0.0094
228 MUSCLE CONTRACTIONS INVOLUNTARY 33 0.0094
229 RED CELL DISTRIBUTION WIDTH INCREASED 39 0.0094
230 ATYPICAL PNEUMONIA 28 0.0094
231 KLEBSIELLA INFECTION 47 0.0093
232 BONE MARROW DISORDER 28 0.0093
233 CARDIOPULMONARY FAILURE 36 0.0092
234 HYPERCALCAEMIA 114 0.0092
235 DECREASED APPETITE 2141 0.0092
236 NEPHROTIC SYNDROME 63 0.0092
237 ESCHERICHIA URINARY TRACT INFECTION 39 0.0092
238 GENERAL PHYSICAL HEALTH DETERIORATION 1051 0.0091
239 RENAL IMPAIRMENT 760 0.0090
240 DERMATITIS ACNEIFORM 55 0.0090
241 BLOOD MAGNESIUM DECREASED 78 0.0090
242 BRAIN NEOPLASM 82 0.0089
243 ENTERITIS 57 0.0089
244 BRONCHOPULMONARY ASPERGILLOSIS 69 0.0089
245 DRUG LEVEL BELOW THERAPEUTIC 49 0.0089
246 PARONYCHIA 39 0.0089
247 PROTEIN URINE PRESENT 44 0.0088
248 BREAST CANCER STAGE IV 25 0.0088
249 GENERALISED OEDEMA 109 0.0088
250 GLOMERULAR FILTRATION RATE DECREASED 108 0.0088
251 MOUTH SWELLING 50 0.0087
252 LUNG INFECTION 133 0.0086
253 DECREASED IMMUNE RESPONSIVENESS 84 0.0086
254 NEOPLASM RECURRENCE 29 0.0085
255 APHAGIA 41 0.0085
256 PNEUMOTHORAX 134 0.0084
257 AMYLASE INCREASED 31 0.0084
258 TONGUE OEDEMA 32 0.0084
259 BACTERIAL INFECTION 156 0.0084
260 POLYNEUROPATHY 100 0.0083
261 UROSEPSIS 77 0.0083
262 ABDOMINAL HERNIA 38 0.0083
263 DEHYDRATION 1111 0.0083
264 YELLOW SKIN 39 0.0083
265 OEDEMA PERIPHERAL 1015 0.0083
266 MUSCULOSKELETAL CHEST PAIN 128 0.0083
267 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 62 0.0083
268 TENDERNESS 86 0.0082
269 SPINAL CORD COMPRESSION 32 0.0082
270 HEPATITIS B REACTIVATION 26 0.0082
271 MULTIPLE ORGAN DYSFUNCTION SYNDROME 232 0.0082
272 GLOSSODYNIA 183 0.0082
273 ERYSIPELAS 41 0.0082
274 GINGIVITIS 44 0.0081
275 BLOOD CALCIUM DECREASED 91 0.0081
276 PNEUMONIA BACTERIAL 74 0.0081
277 PSEUDOMONAS INFECTION 69 0.0080
278 AZOTAEMIA 32 0.0080
279 TASTE DISORDER 162 0.0080
280 HAEMOGLOBIN DECREASED 818 0.0080
281 FOOD INTOLERANCE 29 0.0079
282 HAEMATOTOXICITY 75 0.0079
283 GLOSSITIS 28 0.0079
284 AORTIC VALVE INCOMPETENCE 33 0.0077
285 BACTERIAL SEPSIS 25 0.0077
286 ANAEMIA 1455 0.0076
287 HAEMATOCRIT DECREASED 151 0.0076
288 FIBRIN D DIMER INCREASED 27 0.0076
289 BOWEL MOVEMENT IRREGULARITY 58 0.0076
290 ORAL DISCOMFORT 105 0.0075
291 TONGUE DISCOMFORT 32 0.0075
292 HEPATOMEGALY 74 0.0075
293 HEPATOCELLULAR CARCINOMA 57 0.0075
294 LYMPHOPENIA 106 0.0075
295 LEUKOPENIA 374 0.0075
296 BLOOD CREATINE INCREASED 33 0.0074
297 COVID-19 PNEUMONIA 88 0.0074
298 PULMONARY OEDEMA 333 0.0074
299 CYTOPENIA 91 0.0074
300 BLOOD CALCIUM INCREASED 65 0.0074
301 BREAST CANCER 690 0.0074
302 DEATH 6375 0.0074
303 OEDEMA 399 0.0073
304 PNEUMONIA FUNGAL 29 0.0073
305 THERAPY CHANGE 72 0.0073
306 PROCTALGIA 47 0.0073
307 APLASIA PURE RED CELL 25 0.0073
308 ELECTROLYTE IMBALANCE 84 0.0072
309 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 69 0.0072
310 ORAL HERPES 141 0.0072
311 HYPOALBUMINAEMIA 56 0.0072
312 NECROSIS 40 0.0072
313 ACUTE RESPIRATORY DISTRESS SYNDROME 127 0.0072
314 RENAL CYST 57 0.0072
315 DRUG RESISTANCE 184 0.0072
316 PYELONEPHRITIS 62 0.0071
317 FLANK PAIN 67 0.0071
318 VENOUS THROMBOSIS 28 0.0071
319 ENCEPHALITIS 49 0.0071
320 POLYURIA 58 0.0071
321 THROMBOCYTOPENIA 790 0.0071
322 MASS 98 0.0070
323 WEIGHT DECREASED 1956 0.0070
324 OVARIAN CYST 70 0.0070
325 BONE PAIN 410 0.0070
326 HOSPICE CARE 69 0.0070
327 TOOTHACHE 126 0.0070
328 FAILURE TO THRIVE 36 0.0069
329 BLOOD URIC ACID INCREASED 40 0.0069
330 LARGE INTESTINE PERFORATION 48 0.0069
331 CHOLECYSTITIS 82 0.0069
332 MALNUTRITION 77 0.0069
333 PLATELET COUNT DECREASED 731 0.0069
334 ASPERGILLUS INFECTION 45 0.0068
335 BLOOD PRESSURE INCREASED 1043 0.0068
336 FURUNCLE 54 0.0068
337 PIGMENTATION DISORDER 42 0.0068
338 ABDOMINAL ABSCESS 30 0.0068
339 COUGH 1901 0.0068
340 OESOPHAGEAL ULCER 26 0.0068
341 ENTEROCOLITIS 39 0.0067
342 SKIN MASS 45 0.0067
343 LEFT VENTRICULAR DYSFUNCTION 45 0.0067
344 BLOOD POTASSIUM INCREASED 109 0.0067
345 HYPOXIA 236 0.0067
346 RED BLOOD CELL COUNT DECREASED 189 0.0066
347 LYMPHADENOPATHY 234 0.0066
348 VEIN DISORDER 33 0.0066
349 ACUTE PULMONARY OEDEMA 37 0.0066
350 HYPOCALCAEMIA 124 0.0065
351 DRUG LEVEL ABOVE THERAPEUTIC 30 0.0065
352 SHOCK HAEMORRHAGIC 53 0.0065
353 PARTIAL SEIZURES 34 0.0065
354 CONGESTIVE CARDIOMYOPATHY 27 0.0065
355 BLOOD SODIUM DECREASED 121 0.0064
356 DIARRHOEA 4120 0.0064
357 SEPTIC SHOCK 276 0.0063
358 GENERAL PHYSICAL CONDITION ABNORMAL 43 0.0063
359 DIABETES MELLITUS 483 0.0063
360 AGEUSIA 158 0.0063
361 RENAL PAIN 67 0.0063
362 PYREXIA 2174 0.0063
363 LOCALISED OEDEMA 29 0.0063
364 BLOOD POTASSIUM DECREASED 188 0.0062
365 GASTROINTESTINAL TOXICITY 30 0.0062
366 IMPAIRED HEALING 205 0.0062
367 NASAL DRYNESS 39 0.0062
368 ACNE 471 0.0062
369 NODULE 81 0.0062
370 CYSTITIS HAEMORRHAGIC 25 0.0062
371 FLUID INTAKE REDUCED 31 0.0062
372 EYELID OEDEMA 72 0.0062
373 DYSGEUSIA 459 0.0062
374 ASPARTATE AMINOTRANSFERASE INCREASED 327 0.0061
375 LIPASE INCREASED 47 0.0061
376 BREAST MASS 41 0.0061
377 SMALL INTESTINAL OBSTRUCTION 75 0.0061
378 INTESTINAL OBSTRUCTION 228 0.0060
379 RESPIRATORY FAILURE 439 0.0060
380 ACUTE RESPIRATORY FAILURE 115 0.0060
381 HEPATIC FAILURE 179 0.0059
382 EJECTION FRACTION DECREASED 92 0.0059
383 TRICUSPID VALVE INCOMPETENCE 47 0.0059
384 RENAL DISORDER 274 0.0059
385 DRUG INTOLERANCE 567 0.0059
386 SEIZURE 676 0.0058
387 BLOOD URINE PRESENT 111 0.0058
388 CANDIDA INFECTION 98 0.0058
389 ILEUS 72 0.0058
390 NEEDLE ISSUE 168 0.0058
391 SKIN LESION 158 0.0058
392 BONE MARROW FAILURE 117 0.0058
393 HYPOKALAEMIA 265 0.0057
394 PERIPHERAL SWELLING 883 0.0057
395 HERPES SIMPLEX 37 0.0057
396 GASTROENTERITIS 83 0.0057
397 PANCREATIC DISORDER 28 0.0057
398 METABOLIC DISORDER 33 0.0057
399 HEPATIC FUNCTION ABNORMAL 212 0.0057
400 PLATELET COUNT INCREASED 74 0.0057
401 HYPERVOLAEMIA 28 0.0057
402 GASTROENTERITIS VIRAL 102 0.0056
403 CHOLECYSTITIS ACUTE 32 0.0056
404 BREAST PAIN 60 0.0056
405 TRANSAMINASES INCREASED 125 0.0056
406 DIFFUSE LARGE B-CELL LYMPHOMA 43 0.0056
407 LIVER DISORDER 247 0.0056
408 INTESTINAL PERFORATION 62 0.0055
409 DYSPNOEA EXERTIONAL 208 0.0055
410 SKIN ULCER 142 0.0055
411 PANCYTOPENIA 307 0.0055
412 GASTRITIS 144 0.0055
413 GROIN PAIN 48 0.0055
414 APPETITE DISORDER 36 0.0054
415 GRAFT VERSUS HOST DISEASE 39 0.0054
416 HEPATIC ENZYME ABNORMAL 27 0.0054
417 ULCER 86 0.0054
418 PLEURISY 32 0.0054
419 PULMONARY CONGESTION 71 0.0054
420 VITAMIN D DECREASED 46 0.0054
421 ABNORMAL FAECES 44 0.0054
422 IMMUNOSUPPRESSION 47 0.0053
423 PNEUMONIA 1721 0.0053
424 HYPOMAGNESAEMIA 74 0.0053
425 OESOPHAGITIS 58 0.0053
426 CARDIOMEGALY 65 0.0053
427 FACIAL PARALYSIS 45 0.0053
428 BODY TEMPERATURE INCREASED 107 0.0052
429 ANURIA 45 0.0052
430 SKIN PLAQUE 44 0.0052
431 CHOLELITHIASIS 171 0.0052
432 MOUTH HAEMORRHAGE 38 0.0052
433 LIVER FUNCTION TEST ABNORMAL 150 0.0052
434 ALANINE AMINOTRANSFERASE INCREASED 316 0.0051
435 ASPHYXIA 42 0.0051
436 HEPATIC ENCEPHALOPATHY 48 0.0051
437 HYDROCEPHALUS 28 0.0051
438 MITRAL VALVE INCOMPETENCE 58 0.0051
439 PAPULE 36 0.0051
440 ASTHENIA 1921 0.0051
441 ABDOMINAL PAIN 1187 0.0051
442 JAUNDICE 137 0.0051
443 HYPERKERATOSIS 28 0.0051
444 ENDOCARDITIS 26 0.0051
445 PRODUCTIVE COUGH 242 0.0051
446 EMBOLISM 42 0.0051
447 CHOLESTASIS 97 0.0050
448 COMPRESSION FRACTURE 27 0.0050
449 NEUTROPENIA 685 0.0050
450 INFLAMMATION 260 0.0050
451 BLOOD GLUCOSE ABNORMAL 93 0.0050
452 ABDOMINAL TENDERNESS 25 0.0050
453 RENAL FAILURE 668 0.0050
454 SKIN NECROSIS 26 0.0050
455 TOOTH ABSCESS 51 0.0050
456 BLOOD THYROID STIMULATING HORMONE INCREASED 46 0.0050
457 SQUAMOUS CELL CARCINOMA 47 0.0050
458 PULMONARY ALVEOLAR HAEMORRHAGE 28 0.0050
459 NEUTROPHIL COUNT INCREASED 51 0.0050
460 HYPOTHYROIDISM 159 0.0050
461 BLOOD IRON DECREASED 59 0.0050
462 THERAPY CESSATION 254 0.0049
463 RASH PUSTULAR 36 0.0049
464 FATIGUE 3839 0.0049
465 DYSURIA 181 0.0049
466 SKIN DISORDER 164 0.0049
467 MULTI-ORGAN FAILURE 85 0.0049
468 IRON DEFICIENCY ANAEMIA 45 0.0049
469 DYSPHONIA 285 0.0049
470 THERAPY PARTIAL RESPONDER 76 0.0049
471 MUSCULOSKELETAL PAIN 255 0.0049
472 FAECES DISCOLOURED 105 0.0048
473 ACUTE KIDNEY INJURY 732 0.0048
474 HAEMOPTYSIS 133 0.0048
475 PRODUCT USE IN UNAPPROVED INDICATION 1179 0.0048
476 BRAIN OEDEMA 60 0.0047
477 FAECALOMA 26 0.0047
478 INCONTINENCE 50 0.0047
479 APHONIA 66 0.0047
480 CORONAVIRUS INFECTION 31 0.0047
481 HYPERTENSION 993 0.0047
482 DYSPNOEA 2648 0.0047
483 DERMATITIS 98 0.0047
484 PAIN IN JAW 132 0.0047
485 CARDIAC FAILURE ACUTE 31 0.0046
486 BLOOD BILIRUBIN INCREASED 125 0.0046
487 BASAL CELL CARCINOMA 72 0.0046
488 DRY MOUTH 374 0.0046
489 CARDIAC FAILURE 370 0.0046
490 RASH 2008 0.0046
491 RESPIRATORY DISTRESS 127 0.0046
492 CARDIOMYOPATHY 68 0.0046
493 NEUTROPHIL COUNT DECREASED 187 0.0046
494 FLATULENCE 260 0.0046
495 SEPSIS 511 0.0046
496 GASTROINTESTINAL INFECTION 41 0.0046
497 GLUCOSE TOLERANCE IMPAIRED 27 0.0046
498 VOMITING 2145 0.0046
499 TONGUE DISORDER 33 0.0046
500 BONE DISORDER 83 0.0046
501 TOOTH INFECTION 60 0.0045
502 LIVER FUNCTION TEST INCREASED 97 0.0045
503 OLIGURIA 28 0.0045
504 VIRAL INFECTION 150 0.0045
505 SPINAL COMPRESSION FRACTURE 37 0.0045
506 OROPHARYNGEAL PAIN 411 0.0044
507 STATUS EPILEPTICUS 50 0.0044
508 MELAENA 97 0.0044
509 DYSPHAGIA 416 0.0044
510 ABDOMINAL DISTENSION 457 0.0044
511 BLOOD GLUCOSE INCREASED 822 0.0044
512 IMMUNODEFICIENCY 65 0.0044
513 GASTRIC HAEMORRHAGE 50 0.0043
514 TACHYPNOEA 59 0.0043
515 BLISTER 243 0.0043
516 DRUG INTERACTION 684 0.0043
517 MALAISE 1884 0.0043
518 PULMONARY FIBROSIS 82 0.0043
519 LOW DENSITY LIPOPROTEIN INCREASED 33 0.0043
520 COAGULOPATHY 71 0.0043
521 HAEMORRHOIDS 83 0.0043
522 DUODENAL ULCER 30 0.0042
523 ECCHYMOSIS 29 0.0042
524 PERIPHERAL COLDNESS 58 0.0042
525 SWOLLEN TONGUE 131 0.0042
526 ORAL CANDIDIASIS 55 0.0042
527 RESPIRATORY RATE INCREASED 37 0.0042
528 GASTRIC ULCER 79 0.0042
529 LETHARGY 239 0.0042
530 HEPATITIS B 25 0.0041
531 POSTOPERATIVE WOUND INFECTION 28 0.0041
532 ARTERIOSCLEROSIS 39 0.0041
533 ANGIOEDEMA 183 0.0041
534 EAR INFECTION 110 0.0041
535 FEBRILE NEUTROPENIA 274 0.0041
536 URINARY TRACT INFECTION 704 0.0041
537 ABDOMINAL PAIN UPPER 849 0.0041
538 COLITIS 156 0.0041
539 PULMONARY EMBOLISM 391 0.0041
540 RESPIRATORY TRACT INFECTION 107 0.0041
541 HEPATITIS 105 0.0041
542 RASH GENERALISED 106 0.0041
543 BLOOD COUNT ABNORMAL 62 0.0041
544 HYPOGLYCAEMIA 198 0.0041
545 WHITE BLOOD CELL COUNT DECREASED 442 0.0041
546 ACIDOSIS 31 0.0041
547 HEPATOTOXICITY 90 0.0040
548 RETINAL DETACHMENT 37 0.0040
549 SPUTUM DISCOLOURED 38 0.0040
550 ANAL INCONTINENCE 36 0.0040
551 HAEMATEMESIS 101 0.0040
552 RENAL FAILURE ACUTE 169 0.0040
553 FACE OEDEMA 67 0.0040
554 INFECTION 574 0.0040
555 NEPHROPATHY 37 0.0040
556 HYPERTENSIVE CRISIS 44 0.0040
557 CONSTIPATION 859 0.0039
558 WOUND INFECTION 43 0.0039
559 BLOOD PRESSURE ABNORMAL 78 0.0039
560 TOOTH DISORDER 87 0.0039
561 HAEMOLYSIS 30 0.0039
562 ATAXIA 46 0.0039
563 PHARYNGITIS 48 0.0039
564 CENTRAL NERVOUS SYSTEM LESION 53 0.0039
565 HAEMATURIA 132 0.0039
566 LIP DRY 35 0.0038
567 EPILEPSY 117 0.0038
568 FULL BLOOD COUNT DECREASED 77 0.0038
569 HEPATOCELLULAR INJURY 54 0.0038
570 FACIAL PAIN 34 0.0038
571 GINGIVAL BLEEDING 52 0.0038
572 HYPERTHERMIA 29 0.0038
573 BACTERAEMIA 45 0.0038
574 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 31 0.0038
575 SKIN INFECTION 42 0.0037
576 RHINITIS 30 0.0037
577 BACK PAIN 863 0.0037
578 PULMONARY HAEMORRHAGE 29 0.0037
579 PHARYNGITIS STREPTOCOCCAL 40 0.0037
580 CLOSTRIDIUM DIFFICILE COLITIS 39 0.0037
581 PERITONITIS 76 0.0037
582 EAR PAIN 71 0.0036
583 WOUND 102 0.0036
584 RESPIRATORY DISORDER 109 0.0036
585 LIP SWELLING 121 0.0036
586 NAUSEA 2872 0.0036
587 GENERALISED TONIC-CLONIC SEIZURE 60 0.0036
588 FOLLICULITIS 38 0.0036
589 HEPATIC ENZYME INCREASED 247 0.0036
590 DISSEMINATED INTRAVASCULAR COAGULATION 51 0.0036
591 PATHOGEN RESISTANCE 33 0.0036
592 CELLULITIS 182 0.0036
593 THERAPY NON-RESPONDER 162 0.0036
594 SECRETION DISCHARGE 45 0.0036
595 SINUS TACHYCARDIA 51 0.0036
596 BLOOD PRESSURE DECREASED 238 0.0036
597 MOVEMENT DISORDER 115 0.0036
598 GOUT 64 0.0036
599 HEPATITIS C 43 0.0036
600 PRURITUS GENERALISED 77 0.0036
601 FLUID RETENTION 181 0.0036
602 NEUROTOXICITY 62 0.0035
603 ABNORMAL BEHAVIOUR 140 0.0035
604 GALLBLADDER DISORDER 63 0.0035
605 CLOSTRIDIUM DIFFICILE INFECTION 77 0.0035
606 TUBULOINTERSTITIAL NEPHRITIS 66 0.0035
607 CYSTITIS 112 0.0035
608 TOXICITY TO VARIOUS AGENTS 591 0.0035
609 LOCAL SWELLING 61 0.0035
610 SUDDEN DEATH 37 0.0035
611 SWELLING FACE 227 0.0035
612 RENAL CANCER 165 0.0035
613 ABSCESS 55 0.0034
614 HYPOKINESIA 50 0.0034
615 HYPONATRAEMIA 193 0.0034
616 RHINORRHOEA 219 0.0034
617 ADRENAL INSUFFICIENCY 41 0.0034
618 FEELING COLD 94 0.0034
619 THERAPY INTERRUPTED 241 0.0034
620 UPPER GASTROINTESTINAL HAEMORRHAGE 56 0.0033
621 HEPATIC STEATOSIS 62 0.0033
622 ABDOMINAL PAIN LOWER 84 0.0033
623 HYPOACUSIS 143 0.0033
624 HAEMATOMA 86 0.0033
625 DRY SKIN 442 0.0033
626 HYPERKALAEMIA 116 0.0033
627 SKIN DISCOLOURATION 152 0.0033
628 HEMIPARESIS 56 0.0033
629 PELVIC PAIN 60 0.0033
630 FISTULA 37 0.0033
631 BLOOD GLUCOSE FLUCTUATION 36 0.0033
632 METABOLIC ACIDOSIS 105 0.0033
633 CHILLS 384 0.0033
634 MENSTRUAL DISORDER 27 0.0033
635 HERNIA 63 0.0033
636 FREQUENT BOWEL MOVEMENTS 88 0.0033
637 BLOOD PRESSURE FLUCTUATION 78 0.0032
638 SWELLING 304 0.0032
639 HEMIPLEGIA 27 0.0032
640 MYOPATHY 28 0.0032
641 DIABETES MELLITUS INADEQUATE CONTROL 57 0.0032
642 HEART RATE DECREASED 113 0.0032
643 ERYTHEMA MULTIFORME 30 0.0032
644 CHEST PAIN 595 0.0032
645 APPENDICITIS 30 0.0032
646 DECUBITUS ULCER 26 0.0032
647 DEVICE RELATED INFECTION 49 0.0032
648 THROMBOSIS 256 0.0032
649 GASTROINTESTINAL PAIN 35 0.0032
650 ENCEPHALOPATHY 78 0.0032
651 POLLAKIURIA 132 0.0032
652 DENTAL CARIES 35 0.0032
653 INJECTION SITE INDURATION 41 0.0032
654 PALLOR 86 0.0032
655 INFLUENZA 352 0.0032
656 RASH PRURITIC 171 0.0032
657 OSTEOMYELITIS 57 0.0031
658 HEPATIC CIRRHOSIS 59 0.0031
659 BLOOD GLUCOSE DECREASED 150 0.0031
660 ABDOMINAL DISCOMFORT 523 0.0031
661 NIGHT SWEATS 100 0.0031
662 RETCHING 66 0.0031
663 SPEECH DISORDER 162 0.0031
664 SPINAL OSTEOARTHRITIS 27 0.0031
665 UPPER RESPIRATORY TRACT INFECTION 142 0.0031
666 LEUKOCYTOSIS 55 0.0030
667 HEPATIC CANCER 73 0.0030
668 HYPERSOMNIA 87 0.0030
669 NO THERAPEUTIC RESPONSE 37 0.0030
670 LIGAMENT SPRAIN 30 0.0030
671 WHITE BLOOD CELL COUNT INCREASED 116 0.0030
672 KIDNEY INFECTION 59 0.0030
673 ACUTE HEPATIC FAILURE 41 0.0030
674 INJECTION SITE MASS 110 0.0030
675 EMPHYSEMA 30 0.0030
676 MYELODYSPLASTIC SYNDROME 43 0.0030
677 SKIN CANCER 64 0.0030
678 AMENORRHOEA 52 0.0030
679 SUPRAVENTRICULAR TACHYCARDIA 28 0.0029
680 HERPES ZOSTER 168 0.0029
681 NASOPHARYNGITIS 538 0.0029
682 RIB FRACTURE 60 0.0029
683 DYSSTASIA 85 0.0029
684 JOINT INJURY 62 0.0029
685 HAEMOLYTIC ANAEMIA 26 0.0029
686 DIARRHOEA HAEMORRHAGIC 27 0.0029
687 STAPHYLOCOCCAL INFECTION 95 0.0029
688 TOXIC SKIN ERUPTION 29 0.0029
689 HEART RATE IRREGULAR 65 0.0029
690 CONJUNCTIVITIS 53 0.0029
691 THYROID DISORDER 44 0.0029
692 THIRST 51 0.0029
693 BLOOD TEST ABNORMAL 40 0.0028
694 CHOKING 55 0.0028
695 CIRCULATORY COLLAPSE 48 0.0028
696 MENTAL STATUS CHANGES 78 0.0028
697 APHASIA 84 0.0028
698 NEUROPATHY PERIPHERAL 263 0.0028
699 ASPIRATION 30 0.0027
700 GASTROINTESTINAL HAEMORRHAGE 228 0.0027
701 HYPERBILIRUBINAEMIA 28 0.0027
702 PAIN IN EXTREMITY 795 0.0027
703 EYE SWELLING 100 0.0027
704 MYOCLONUS 32 0.0027
705 JOINT SWELLING 322 0.0027
706 DEEP VEIN THROMBOSIS 173 0.0027
707 EYE INFECTION 30 0.0027
708 DRY THROAT 27 0.0027
709 IMMUNE SYSTEM DISORDER 35 0.0027
710 ACUTE MYELOID LEUKAEMIA 41 0.0026
711 HYPERTHYROIDISM 38 0.0026
712 GLYCOSYLATED HAEMOGLOBIN INCREASED 66 0.0026
713 LOCALISED INFECTION 63 0.0026
714 HYPOTENSION 522 0.0026
715 PNEUMONIA ASPIRATION 65 0.0026
716 CYST 32 0.0026
717 PAIN 1577 0.0026
718 FLUSHING 259 0.0025
719 SCAB 29 0.0025
720 INTERNAL HAEMORRHAGE 29 0.0025
721 DISORIENTATION 100 0.0025
722 POOR VENOUS ACCESS 26 0.0025
723 CONFUSIONAL STATE 405 0.0025
724 ILLNESS 258 0.0025
725 MUSCULOSKELETAL DISCOMFORT 43 0.0025
726 SKIN EXFOLIATION 210 0.0025
727 CEREBRAL HAEMORRHAGE 89 0.0025
728 CYANOSIS 39 0.0025
729 PHARYNGEAL OEDEMA 38 0.0025
730 RESPIRATORY ARREST 68 0.0025
731 SCRATCH 26 0.0025
732 FUNGAL INFECTION 82 0.0025
733 PULMONARY HYPERTENSION 51 0.0024
734 CONTUSION 234 0.0024
735 DECREASED ACTIVITY 26 0.0024
736 TREATMENT FAILURE 199 0.0024
737 ERYTHEMA 491 0.0024
738 HOT FLUSH 179 0.0024
739 PANCREATITIS 125 0.0024
740 NASAL CONGESTION 138 0.0023
741 HEART RATE INCREASED 232 0.0023
742 NERVOUSNESS 122 0.0023
743 GAIT INABILITY 78 0.0023
744 PRURITUS 895 0.0023
745 PRODUCT USE ISSUE 436 0.0023
746 GASTROINTESTINAL DISORDER 207 0.0023
747 GAIT DISTURBANCE 438 0.0023
748 MICTURITION URGENCY 26 0.0023
749 ACUTE MYOCARDIAL INFARCTION 67 0.0023
750 BRONCHITIS 168 0.0023
751 BLOOD CREATINE PHOSPHOKINASE INCREASED 65 0.0023
752 HYPOAESTHESIA ORAL 34 0.0023
753 COVID-19 395 0.0022
754 MYALGIA 382 0.0022
755 MOOD ALTERED 61 0.0022
756 PARALYSIS 32 0.0022
757 ARTHRALGIA 929 0.0022
758 URINARY INCONTINENCE 66 0.0022
759 MYELOSUPPRESSION 80 0.0022
760 SINUSITIS 226 0.0022
761 WHEEZING 130 0.0022
762 SEASONAL ALLERGY 31 0.0022
763 HEADACHE 1368 0.0022
764 THERAPEUTIC RESPONSE DECREASED 132 0.0022
765 OFF LABEL USE 1901 0.0022
766 CHROMATURIA 49 0.0022
767 HAIR COLOUR CHANGES 27 0.0022
768 LUNG NEOPLASM MALIGNANT 89 0.0022
769 ABASIA 53 0.0021
770 NOCTURIA 26 0.0021
771 SNEEZING 48 0.0021
772 TYPE 2 DIABETES MELLITUS 72 0.0021
773 LABORATORY TEST ABNORMAL 63 0.0021
774 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117 0.0021
775 CEREBRAL INFARCTION 52 0.0021
776 SLEEP DISORDER 150 0.0021
777 DYSPEPSIA 209 0.0021
778 SARS-COV-2 TEST POSITIVE 28 0.0021
779 ERUCTATION 41 0.0021
780 OXYGEN SATURATION DECREASED 119 0.0021
781 HAEMORRHAGE 220 0.0021
782 DRUG-INDUCED LIVER INJURY 66 0.0021
783 ALOPECIA 412 0.0021
784 URINARY RETENTION 70 0.0021
785 RECTAL HAEMORRHAGE 90 0.0021
786 CHRONIC KIDNEY DISEASE 159 0.0021
787 MALIGNANT MELANOMA 28 0.0021
788 DIABETIC KETOACIDOSIS 50 0.0021
789 CARDIAC FAILURE CONGESTIVE 167 0.0021
790 AGGRESSION 104 0.0021
791 LIMB DISCOMFORT 64 0.0021
792 COMPLICATION ASSOCIATED WITH DEVICE 30 0.0021
793 CHEST DISCOMFORT 211 0.0021
794 TACHYCARDIA 183 0.0021
795 SKIN REACTION 29 0.0021
796 IMPAIRED GASTRIC EMPTYING 28 0.0021
797 PANCREATITIS ACUTE 46 0.0020
798 DELIRIUM 71 0.0020
799 LOWER RESPIRATORY TRACT INFECTION 93 0.0020
800 NEPHROLITHIASIS 93 0.0020
801 BREAST CANCER FEMALE 54 0.0020
802 SYNCOPE 202 0.0020
803 UPPER LIMB FRACTURE 40 0.0020
804 NECK PAIN 112 0.0020
805 FLUID OVERLOAD 29 0.0020
806 NERVOUS SYSTEM DISORDER 62 0.0020
807 DIVERTICULITIS 55 0.0020
808 MENSTRUATION IRREGULAR 53 0.0020
809 ELECTROCARDIOGRAM QT PROLONGED 71 0.0020
810 ISCHAEMIC STROKE 35 0.0020
811 LIVER INJURY 48 0.0020
812 LACRIMATION INCREASED 59 0.0020
813 SCIATICA 31 0.0019
814 ARRHYTHMIA 92 0.0019
815 PARAESTHESIA ORAL 28 0.0019
816 CARDIO-RESPIRATORY ARREST 81 0.0019
817 RASH MACULO-PAPULAR 43 0.0019
818 SCAR 33 0.0019
819 RHABDOMYOLYSIS 80 0.0019
820 DEAFNESS 50 0.0019
821 INSOMNIA 509 0.0019
822 OSTEOPENIA 29 0.0019
823 POOR QUALITY SLEEP 41 0.0019
824 FRACTURE 36 0.0019
825 DIZZINESS 941 0.0019
826 HAEMATOCHEZIA 104 0.0019
827 BURNING SENSATION 132 0.0019
828 SHOCK 43 0.0019
829 FEELING ABNORMAL 448 0.0019
830 HIP FRACTURE 60 0.0019
831 MUSCULAR WEAKNESS 211 0.0019
832 DISCOMFORT 113 0.0019
833 ANGINA PECTORIS 53 0.0018
834 OSTEOPOROSIS 76 0.0018
835 LOWER LIMB FRACTURE 35 0.0018
836 DRUG INEFFECTIVE 2382 0.0018
837 HEAD INJURY 57 0.0018
838 INFLUENZA LIKE ILLNESS 148 0.0018
839 DEPRESSED MOOD 95 0.0018
840 ATRIAL FIBRILLATION 172 0.0018
841 OSTEONECROSIS 58 0.0018
842 COMA 84 0.0018
843 HOSPITALISATION 271 0.0018
844 FALL 585 0.0018
845 LOSS OF CONSCIOUSNESS 225 0.0018
846 HEAD DISCOMFORT 31 0.0017
847 HYPERSENSITIVITY 325 0.0017
848 HYPOAESTHESIA 262 0.0017
849 FEMUR FRACTURE 54 0.0017
850 EYE DISORDER 57 0.0017
851 GASTROOESOPHAGEAL REFLUX DISEASE 138 0.0017
852 PRODUCT AVAILABILITY ISSUE 39 0.0017
853 ALTERED STATE OF CONSCIOUSNESS 37 0.0017
854 END STAGE RENAL DISEASE 31 0.0017
855 SPINAL FRACTURE 34 0.0017
856 LIMB INJURY 46 0.0017
857 SKIN FISSURES 33 0.0017
858 ROAD TRAFFIC ACCIDENT 70 0.0017
859 CARDIAC DISORDER 156 0.0017
860 POST PROCEDURAL COMPLICATION 32 0.0017
861 CATARACT 98 0.0016
862 NEURALGIA 40 0.0016
863 DISEASE RECURRENCE 78 0.0016
864 TREMOR 272 0.0016
865 GASTRIC DISORDER 56 0.0016
866 OSTEOARTHRITIS 69 0.0016
867 CONVULSION 93 0.0016
868 SINUS DISORDER 32 0.0016
869 RASH ERYTHEMATOUS 77 0.0016
870 RASH PAPULAR 36 0.0016
871 INJECTION SITE WARMTH 33 0.0016
872 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 289 0.0016
873 MEMORY IMPAIRMENT 218 0.0016
874 PROCEDURAL PAIN 44 0.0016
875 MENORRHAGIA 31 0.0016
876 PARAESTHESIA 247 0.0016
877 INTERNATIONAL NORMALISED RATIO INCREASED 44 0.0015
878 SOMNOLENCE 309 0.0015
879 FEELING HOT 94 0.0015
880 CARDIAC ARREST 126 0.0015
881 DRY EYE 76 0.0015
882 AMNESIA 99 0.0015
883 CORONARY ARTERY DISEASE 46 0.0015
884 INCREASED APPETITE 29 0.0015
885 URTICARIA 253 0.0015
886 DIPLOPIA 39 0.0015
887 CARDIOVASCULAR DISORDER 38 0.0015
888 DRUG ERUPTION 26 0.0015
889 AGRANULOCYTOSIS 27 0.0015
890 MUSCLE SPASMS 264 0.0014
891 OCULAR HYPERAEMIA 68 0.0014
892 EOSINOPHILIA 25 0.0014
893 PRODUCT PRESCRIBING ISSUE 31 0.0014
894 WEIGHT INCREASED 315 0.0014
895 THROAT IRRITATION 63 0.0014
896 DEPRESSED LEVEL OF CONSCIOUSNESS 55 0.0014
897 ILL-DEFINED DISORDER 84 0.0014
898 IRRITABILITY 83 0.0014
899 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 98 0.0014
900 ANXIETY 391 0.0014
901 CEREBROVASCULAR ACCIDENT 230 0.0014
902 DRUG PRESCRIBING ERROR 26 0.0014
903 TOOTH LOSS 28 0.0013
904 ADVERSE DRUG REACTION 121 0.0013
905 UNRESPONSIVE TO STIMULI 34 0.0013
906 VERTIGO 80 0.0013
907 DYSARTHRIA 49 0.0013
908 BLINDNESS 53 0.0013
909 ECZEMA 68 0.0013
910 GLAUCOMA 25 0.0013
911 PALPITATIONS 152 0.0013
912 BALANCE DISORDER 112 0.0013
913 MOBILITY DECREASED 93 0.0013
914 CRYING 47 0.0013
915 DEMENTIA 36 0.0013
916 PSYCHOTIC DISORDER 38 0.0013
917 DEPRESSION 290 0.0013
918 MIGRAINE 121 0.0013
919 COGNITIVE DISORDER 59 0.0013
920 EMOTIONAL DISORDER 38 0.0012
921 RASH MACULAR 43 0.0012
922 MEDICATION ERROR 68 0.0012
923 PANCREATIC CARCINOMA 35 0.0012
924 VISUAL IMPAIRMENT 150 0.0012
925 AGITATION 88 0.0012
926 HYPERHIDROSIS 153 0.0012
927 PRODUCT DOSE OMISSION 77 0.0012
928 CONDITION AGGRAVATED 355 0.0012
929 MOOD SWINGS 36 0.0011
930 MYOCARDIAL INFARCTION 195 0.0011
931 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 79 0.0011
932 DYSKINESIA 45 0.0011
933 ANGER 37 0.0011
934 FEAR 29 0.0011
935 PAIN OF SKIN 28 0.0010
936 JOINT STIFFNESS 27 0.0010
937 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 53 0.0010
938 VISUAL ACUITY REDUCED 33 0.0010
939 RESTLESSNESS 36 0.0010
940 VISION BLURRED 132 0.0010
941 SKIN IRRITATION 44 0.0010
942 ARTHRITIS 75 0.0010
943 ASTHMA 106 0.0009
944 RENAL INJURY 27 0.0009
945 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 183 0.0009
946 INTENTIONAL PRODUCT USE ISSUE 79 0.0009
947 EYE PRURITUS 30 0.0009
948 MENTAL DISORDER 38 0.0009
949 NO ADVERSE EVENT 157 0.0009
950 PREMATURE BABY 26 0.0009
951 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
952 DISTURBANCE IN ATTENTION 46 0.0009
953 SURGERY 50 0.0009
954 PRODUCT DOSE OMISSION ISSUE 248 0.0008
955 LACTIC ACIDOSIS 26 0.0008
956 PLASMA CELL MYELOMA 30 0.0008
957 INCORRECT DOSE ADMINISTERED 174 0.0008
958 TINNITUS 35 0.0008
959 VAGINAL HAEMORRHAGE 33 0.0008
960 ANAPHYLACTIC REACTION 42 0.0008
961 ADVERSE EVENT 70 0.0008
962 INJECTION SITE PAIN 227 0.0007
963 ARTHROPATHY 40 0.0007
964 BRADYCARDIA 38 0.0007
965 EYE PAIN 39 0.0007
966 HALLUCINATION 52 0.0007
967 MUSCULOSKELETAL STIFFNESS 60 0.0007
968 INJURY 46 0.0007
969 INJECTION SITE SWELLING 50 0.0007
970 TREATMENT NONCOMPLIANCE 33 0.0006
971 THERAPEUTIC RESPONSE UNEXPECTED 27 0.0006
972 PRODUCT SUBSTITUTION ISSUE 34 0.0006
973 UNDERDOSE 40 0.0005
974 EYE IRRITATION 29 0.0005
975 UNEVALUABLE EVENT 37 0.0005
976 MATERNAL EXPOSURE DURING PREGNANCY 41 0.0005
977 FOETAL EXPOSURE DURING PREGNANCY 37 0.0005
978 EXPOSURE DURING PREGNANCY 26 0.0004
979 DRUG DOSE OMISSION 68 0.0004
980 OVERDOSE 86 0.0004
981 SKIN BURNING SENSATION 28 0.0004
982 PROSTATE CANCER 31 0.0004
983 INJECTION SITE BRUISING 29 0.0004
984 INJECTION SITE HAEMORRHAGE 27 0.0003
985 PSORIASIS 44 0.0003
986 PRODUCT STORAGE ERROR 29 0.0003
987 SUICIDAL IDEATION 26 0.0003
988 INJECTION SITE ERYTHEMA 33 0.0003
989 PRODUCT QUALITY ISSUE 35 0.0003
990 EMOTIONAL DISTRESS 25 0.0002